StartGroepenDiscussieMeerTijdgeest
Doorzoek de site
Onze site gebruikt cookies om diensten te leveren, prestaties te verbeteren, voor analyse en (indien je niet ingelogd bent) voor advertenties. Door LibraryThing te gebruiken erken je dat je onze Servicevoorwaarden en Privacybeleid gelezen en begrepen hebt. Je gebruik van de site en diensten is onderhevig aan dit beleid en deze voorwaarden.

Resultaten uit Google Boeken

Klik op een omslag om naar Google Boeken te gaan.

Bezig met laden...

New Medicines: Issues of Approval, Access, and Product Safety (Science and Society)

door Daniel E. Harmon

LedenBesprekingenPopulariteitGemiddelde beoordelingDiscussies
1Geen7,761,377GeenGeen
Medicines unquestionably save lives and improve health and the quality of life. On rare occasions, they also harm and kill those who take them. Lab scientists around the world experiment with new medications to combat illnesses and to relieve pain and stress. Sometimes, even when they are used properly, the medicines' effects are not entirely good. Drugs approved by the U.S. Food and Drug Administration regularly are found to produce unforeseen and dangerous, sometimes deadly, side effects--after years of prescribed use, in some cases. That is why extensive testing is required before a new medication becomes available to the general public. Yet many consumers do not understand why the FDA seems to drag its feet in approving new medications that offer terminally ill patients hope for a cure. In this engrossing book, readers learn about the disagreement over the process of developing and distributing medicines. They understand the distrust toward drug makers, government regulators, and distributors, and examine the questions of timing and costs. But what about those cases in which the side effects of a dangerous drug have not come to light until many years after the drug was approved for marketing? How many years should scientists, drug companies, FDA officials, and doctors wait before the testing ends and they can introduce a new medicine, concluding that it is safe to use?… (meer)
Onlangs toegevoegd doorssa.books
Geen
Bezig met laden...

Meld je aan bij LibraryThing om erachter te komen of je dit boek goed zult vinden.

Op dit moment geen Discussie gesprekken over dit boek.

Geen besprekingen
geen besprekingen | voeg een bespreking toe
Je moet ingelogd zijn om Algemene Kennis te mogen bewerken.
Voor meer hulp zie de helppagina Algemene Kennis .
Gangbare titel
Oorspronkelijke titel
Alternatieve titels
Oorspronkelijk jaar van uitgave
Mensen/Personages
Belangrijke plaatsen
Belangrijke gebeurtenissen
Verwante films
Motto
Opdracht
Eerste woorden
Citaten
Laatste woorden
Ontwarringsbericht
Uitgevers redacteuren
Auteur van flaptekst/aanprijzing
Oorspronkelijke taal
Gangbare DDC/MDS
Canonieke LCC

Verwijzingen naar dit werk in externe bronnen.

Wikipedia in het Engels

Geen

Medicines unquestionably save lives and improve health and the quality of life. On rare occasions, they also harm and kill those who take them. Lab scientists around the world experiment with new medications to combat illnesses and to relieve pain and stress. Sometimes, even when they are used properly, the medicines' effects are not entirely good. Drugs approved by the U.S. Food and Drug Administration regularly are found to produce unforeseen and dangerous, sometimes deadly, side effects--after years of prescribed use, in some cases. That is why extensive testing is required before a new medication becomes available to the general public. Yet many consumers do not understand why the FDA seems to drag its feet in approving new medications that offer terminally ill patients hope for a cure. In this engrossing book, readers learn about the disagreement over the process of developing and distributing medicines. They understand the distrust toward drug makers, government regulators, and distributors, and examine the questions of timing and costs. But what about those cases in which the side effects of a dangerous drug have not come to light until many years after the drug was approved for marketing? How many years should scientists, drug companies, FDA officials, and doctors wait before the testing ends and they can introduce a new medicine, concluding that it is safe to use?

Geen bibliotheekbeschrijvingen gevonden.

Boekbeschrijving
Haiku samenvatting

Actuele discussies

Geen

Populaire omslagen

Snelkoppelingen

Waardering

Gemiddelde: Geen beoordelingen.

Ben jij dit?

Word een LibraryThing Auteur.

 

Over | Contact | LibraryThing.com | Privacy/Voorwaarden | Help/Veelgestelde vragen | Blog | Winkel | APIs | TinyCat | Nagelaten Bibliotheken | Vroege Recensenten | Algemene kennis | 205,703,011 boeken! | Bovenbalk: Altijd zichtbaar